DarioHealth shareholders approve all seven proposals at 2026 Annual Meeting

DarioHealth Corp.

Directors elected: Hila Karah, Dennis Matheis, Dennis M. McGrath, Erez Raphael, Yoav Shaked, Lawrence Leisure, Adam K. Stern.
Ratified Kesselman & Kesselman (PwC) as auditor for FY 2026 (4,952,777 for, 17,242 against).
Approved conversion of 25,605 Series D/D-1/D-2/D-3 preferred shares into 1,697,843 common shares, plus dividend and lock-up shares.
Ratified issuance of common shares upon exercise of pre-funded warrants, warrants and RSUs from Twill acquisition.
Approved increase in equity incentive plan by 500,000 shares and charter amendment allowing board to amend bylaws.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.